General form of registration statement for all companies including face-amount certificate companies

Reverse Acquisition (Details Narrative) (10-K)

v3.10.0.1
Reverse Acquisition (Details Narrative) (10-K) - USD ($)
 12 Months Ended
Oct. 04, 2017
Sep. 29, 2017
Dec. 31, 2017
Mar. 31, 2018
Dec. 31, 2016
Common stock shares issued     35,272,626 35,272,626 31,745,242
Common stock shares outstanding     35,272,626 35,272,626 31,745,242
Promet Therapeutics LLC [Member]          
General and administrative expense     $ 58,763    
Parent Company [Member]          
Business acquisition acquired value $ 1,017,342        
Business acquisition exchange percentage 90.00%        
Business acquisition of common stock issued shares 222,217,112        
Stock issued during reserve split 31,745,242 1,850,625 35,272,626    
Common stock shares issued     246,907,902 35,272,626  
Common stock shares outstanding     246,907,902 35,272,626